Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.

Jeetesh Patel, Hoong Lim, Kiran Rohalu, Elizabeth Hughes, Gregory Lip

Research output: Contribution to journalArticle

16 Citations (Scopus)


Background. Abnormal adipocyte function is implicated in the coalition of multiple cardiovascular risk factors, where aberrant circulating levels of the adipose-derived hormones adiponectin, leptin, and tumour necrosis factor (TNF) alpha may provide the putative link between hypertension and increased cardiovascular risk. The pragmatic utility of these 'adipocytokines' in the clinical setting of hypertension is unclear, and we hypothesized a relationship of circulating adipocytokines to hypertension, and associated cardiovascular morbidity. Method. Using a cross-sectional approach, we measured plasma adipocytokines in 278 'high-risk' treated hypertensive participants of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) study (mean (SD) age 62.9 (7.7) years), who were compared to 54 newly diagnosed untreated hypertensives (61.3 (10.9) years) and 55 healthy controls (48.3 (12.3) years). Results. Levels of all three adipocytokines were lower amongst treated hypertensives compared to newly diagnosed hypertensives and healthy controls (P
Original languageEnglish
Pages (from-to)1-10
Number of pages10
JournalAnnals of Medicine
Publication statusPublished - 26 Jan 2009


Dive into the research topics of 'Circulating levels of adiponectin, leptin, and tumour necrosis factor alpha in hypertension.'. Together they form a unique fingerprint.

Cite this